Skip to main content
Anam, 17-years-old DR-TB patient
An MSF staff speaks with Anam*, a 17-year-old patient living with drug-resistant tuberculosis, and her mother outside the MSF clinic in Chembur. Mumbai, India, May 2023.
© Premananda Hessenkamp

In Mumbai, we treat complex cases of drug-resistant tuberculosis and work with health authorities to reduce high tuberculosis incidence and death rates in the area. We also provide comprehensive care to people living with advanced HIV in Bihar, essential healthcare via mobile clinics in remote areas of Chhattisgarh, and mental health services in Jammu and Kashmir. 

Our activities in 2023 in India

Data and information from the International Activity Report 2023.

MSF in India in 2023 Médecins Sans Frontières (MSF) runs programmes in India aimed at improving care for tuberculosis (TB), HIV and other infectious diseases, and access to essential healthcare for remote communities.
India IAR map 2023
Country map for the IAR 2023.
© MSF
In 2023
Kala azar-HIV co-infection in Bihar, Animated explainer | ENG
video

Explaining kala azar-HIV co-infection

Have you heard of kala azar?

Kala azar is a neglected but potentially fatal tropical disease. India accounts for 30 per cent of cases worldwide.

This short animation explains what kala azar is, how it relates to HIV, and what we are doing in response.

Since 80 per cent of India's kala azar cases are reported in Bihar, we set up a programme there in 2007.

People living with HIV are particularly vulnerable to kala azar, so since 2016 we have been focusing on treating patients co-infected with the two diseases, in partnership with the Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Bihar.

Filter Tips
  • Try a different country, year, format, or topic.
  • Clear one or more filters

Contact us

Zoya, qui a été soignée pour une co-infection kala-azar-VIH et tuberculose au Bihar